Eli Lilly's Dual-Action Tirzepatide Breakthrough
Mounjaro and Zepbound contain tirzepatide, a groundbreaking dual GLP-1/GIP receptor agonist manufactured by Eli Lilly. Mounjaro is FDA-approved for type 2 diabetes, while Zepbound is approved specifically for weight management. Clinical trials show superior weight loss compared to semaglutide-based medications, making it the most effective GLP-1 option currently available.
Tirzepatide is a first-in-class medication that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism provides enhanced appetite suppression and metabolic benefits compared to GLP-1-only medications. Administered as a once-weekly injection, it represents the next generation of weight management therapy.
💡 Looking for better value? Check out our #1 recommended provider, Coreage RX — Compounded tirzepatide starting at just $129/month with fast shipping and easy reordering.
The SURMOUNT clinical trials demonstrated remarkable results. Participants taking the highest dose of Zepbound (15mg) lost an average of 20.9% of their body weight over 72 weeks—outperforming semaglutide in head-to-head comparisons. For a 200-pound person, this represents over 40 pounds of weight loss.
In the SURMOUNT-2 trial, tirzepatide demonstrated superior weight loss compared to semaglutide (Wegovy/Ozempic), with participants losing an additional 5-7% more body weight on average. This makes it the most effective weight loss medication currently available.
Retail Price: $900-$1,200 per month without insurance
With Insurance: Mounjaro may be covered for diabetes; Zepbound coverage for weight loss varies by plan. Copays typically $25-$500/month.
Savings Programs: Eli Lilly offers a savings card that may reduce out-of-pocket costs to $25/month for eligible commercially insured patients (up to $550 savings per prescription).
✓ Availability Status
As of 2024-2026, tirzepatide availability has improved compared to earlier supply constraints. Both Mounjaro and Zepbound are generally available, though local pharmacy stock may vary.
Ideal candidates include:
Not recommended for:
Mounjaro and Zepbound represent the cutting edge of weight management therapy. With superior efficacy compared to all other GLP-1 medications, they earn our "Most Effective" designation and a perfect 5.0 rating.
If maximum weight loss is your priority and you have access to insurance coverage or savings programs, tirzepatide is the premier choice. The dual GLP-1/GIP mechanism delivers results that outperform semaglutide-based medications, making it worth considering despite the premium price. However, those without coverage should carefully evaluate the high cost versus potential benefits, or consider compounded tirzepatide options.
Most Effective Option
⚠️ IMPORTANT DISCLOSURE
This review may be influenced by our financial relationships with GLP-1 providers. We may receive compensation for referrals. Please read our full disclosure policy and consult with a licensed healthcare provider before starting any medication. See our medical disclaimer.
Compare prices and availability from trusted providers
Premium Compounded GLP-1 at an Unbeatable Price
Special pricing available • Online consultation in minutes
⚠️ DISCLOSURE: We may earn a commission from Coreage RX referrals
This recommendation may be influenced by our financial relationship with Coreage RX. See our full disclosure policy.
Explore our full range of independent reviews
Our #1 pick! Premium compounded GLP-1 starting at just $79/month. Unbeatable value for the price with both semaglutide and tirzepatide options, lightning-fast shipping to your door, effortless reordering process, and responsive customer service via email. The complete package for your weight loss journey.
Budget-friendly compounded tirzepatide at just $199/month all-inclusive. Medical evaluation and ongoing support included with transparent, affordable pricing.
Men's health platform offering GLP-1 weight loss with unique microdose options. Available nationwide with semaglutide and tirzepatide, plus budget-friendly low-dose plans starting at $79.99/month.
Outcome-driven telehealth platform with personalized compounded semaglutide and expert clinical support. Focus on weight loss, hormone health, and longevity with comprehensive care.
Allergy and weight loss telehealth platform offering compounded GLP-1 medications with vitamin B12. Competitive pricing starting at $199/month with HSA/FSA acceptance and no insurance required.
Wellness-focused telehealth offering compounded semaglutide and tirzepatide from 503B facilities. Affordable consultation fees at $89 with personalized weight loss solutions.